97 related articles for article (PubMed ID: 18684400)
1. Preparation of estradiol chitosan nanoparticles for improving nasal absorption and brain targeting.
Wang X; Chi N; Tang X
Eur J Pharm Biopharm; 2008 Nov; 70(3):735-40. PubMed ID: 18684400
[TBL] [Abstract][Full Text] [Related]
2. Development and optimization of in-situ gel containing chitosan nanoparticles for possible nose-to-brain delivery of vinpocetine.
Hard SAAA; Shivakumar HN; Redhwan MAM
Int J Biol Macromol; 2023 Dec; 253(Pt 6):127217. PubMed ID: 37793522
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study.
Alam S; Khan ZI; Mustafa G; Kumar M; Islam F; Bhatnagar A; Ahmad FJ
Int J Nanomedicine; 2012; 7():5705-18. PubMed ID: 23180965
[TBL] [Abstract][Full Text] [Related]
4. Transferrin functionalized poloxamer-chitosan nanoparticles of metformin: physicochemical characterization,
Birajdar SV; Mazahir F; Yadav AK
Drug Dev Ind Pharm; 2023 Dec; 49(12):734-747. PubMed ID: 37982183
[TBL] [Abstract][Full Text] [Related]
5. Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate.
Rassu G; Soddu E; Cossu M; Brundu A; Cerri G; Marchetti N; Ferraro L; Regan RF; Giunchedi P; Gavini E; Dalpiaz A
J Control Release; 2015 Mar; 201():68-77. PubMed ID: 25620068
[TBL] [Abstract][Full Text] [Related]
6. Chitosan/Cyclodextrin/TPP Nanoparticles Loaded with Quercetin as Novel Bacterial Quorum Sensing Inhibitors.
Thanh Nguyen H; Goycoolea FM
Molecules; 2017 Nov; 22(11):. PubMed ID: 29140285
[TBL] [Abstract][Full Text] [Related]
7. Delivery of cefotaxime to the brain via intranasal administration.
Manda P; Hargett JK; Vaka SR; Repka MA; Murthy SN
Drug Dev Ind Pharm; 2011 Nov; 37(11):1306-10. PubMed ID: 21702731
[TBL] [Abstract][Full Text] [Related]
8. Investigating the Correlation Between Drug Physical Properties and Physical Characteristics and Drug Entrapment Efficiencies of Chitosan-TPP Nanoparticles.
Jaradat A; Obeidat WM
J Pharm Sci; 2023 Dec; 112(12):3185-3196. PubMed ID: 37751806
[TBL] [Abstract][Full Text] [Related]
9. Preparation of novel S-allyl cysteine chitosan based nanoparticles for use in ischemic brain treatment.
Khan MF; Ahmad N; Alkholifi FK; Ullah Z; Khalid MS; Akhtar S; Farooqui S; Khan N; Chaudhary AA; Alawam AS; Ali MAM
RSC Adv; 2024 Jan; 14(1):160-180. PubMed ID: 38173594
[No Abstract] [Full Text] [Related]
10. Intranasal delivery of chitosan nanoparticles for migraine therapy.
Gulati N; Nagaich U; Saraf SA
Sci Pharm; 2013; 81(3):843-54. PubMed ID: 24106677
[TBL] [Abstract][Full Text] [Related]
11. Nose to brain delivery of naringin-loaded chitosan nanoparticles for potential use in oxaliplatin-induced chemobrain in rats: impact on oxidative stress, cGAS/STING and HMGB1/RAGE/TLR2/MYD88 inflammatory axes.
Hanna DMF; Youshia J; Fahmy SF; George MY
Expert Opin Drug Deliv; 2023; 20(12):1859-1873. PubMed ID: 37357778
[TBL] [Abstract][Full Text] [Related]
12. Microfluidic Synthesis of Ultrasmall Chitosan/Graphene Quantum Dots Particles for Intranasal Delivery in Alzheimer's Disease Treatment.
Mohebichamkhorami F; Faizi M; Mahmoudifard M; Hajikarim-Hamedani A; Mohseni SS; Heidari A; Ghane Y; Khoramjouy M; Khayati M; Ghasemi R; Zali H; Hosseinzadeh S; Mostafavi E
Small; 2023 Oct; 19(40):e2207626. PubMed ID: 37309299
[TBL] [Abstract][Full Text] [Related]
13. Dimeric ferulic acid conjugate as a prodrug for brain targeting after nasal administration of loaded solid lipid microparticles.
Botti G; Bianchi A; Dalpiaz A; Tedeschi P; Albanese V; Sorrenti M; Catenacci L; Bonferoni MC; Beggiato S; Pavan B
Expert Opin Drug Deliv; 2023; 20(11):1657-1679. PubMed ID: 38014509
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive review of advanced nasal delivery: Specially insulin and calcitonin.
Luo D; Ni X; Yang H; Feng L; Chen Z; Bai L
Eur J Pharm Sci; 2024 Jan; 192():106630. PubMed ID: 37949195
[TBL] [Abstract][Full Text] [Related]
15. Intranasal administration of dantrolene increased brain concentration and duration.
Wang J; Shi Y; Yu S; Wang Y; Meng Q; Liang G; Eckenhoff MF; Wei H
PLoS One; 2020; 15(3):e0229156. PubMed ID: 32160210
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
[TBL] [Abstract][Full Text] [Related]
17. Nose-to-brain drug delivery by nanoparticles in the treatment of neurological disorders.
Ong WY; Shalini SM; Costantino L
Curr Med Chem; 2014; 21(37):4247-56. PubMed ID: 25039773
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer's Disease Management.
Dighe S; Jog S; Momin M; Sawarkar S; Omri A
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38258068
[TBL] [Abstract][Full Text] [Related]
19. Silencing of the 20S proteasomal subunit-α6 triggers full oogenesis arrest and increased mRNA levels of the selective autophagy adaptor protein p62/SQSTM1 in the ovary of the vector Rhodnius prolixus.
Faria-Reis A; Santos-Araújo S; Pereira J; Rios T; Majerowicz D; Gondim KC; Ramos I
PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011380. PubMed ID: 37267415
[TBL] [Abstract][Full Text] [Related]
20. Nasotransmucosal Delivery of Curcumin-Loaded Mucoadhesive Microemulsions for Treating Inflammation-Related CNS Disorders.
Patel MS; Mandal SD; Mandal S; Faldu S; Patel J
Turk J Pharm Sci; 2022 Oct; 19(5):560-571. PubMed ID: 36317931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
